Yahoo! Finance: Top Stories

Blueprint Medicines Soars 26% on $9.5 Billion Buyout. Why This Drug Is Key to the Deal.

Jun 2, 2025 - 15:22
 0
Blueprint Medicines Soars 26% on $9.5 Billion Buyout. Why This Drug Is Key to the Deal.
Read More

Tags:

Previous Article

Boeing Stock Just Got Upgraded. Why This Analyst Says Shares Can Gain 25%.

Next Article

These Stocks Are Moving the Most Today: Cleveland-Cliffs, Tesla, Blueprint Medic...

Related Posts

International Business Machines (IBM): AI and Hybrid Cloud Strategy Drives $290 Price Target

International Business Machines (IBM): AI and Hybrid Cl...

May 14, 2025  0

Stocks Pare Losses. Wall Street Bets Trump Is Bluffing Again.

Stocks Pare Losses. Wall Street Bets Trump Is Bluffing ...

May 23, 2025  0

Tesla Europe Sales Slumped. Why the Stock Is Rising.

Tesla Europe Sales Slumped. Why the Stock Is Rising.

May 27, 2025  0